131 related articles for article (PubMed ID: 4877423)
1. Antibody production in urinary bladder infection.
Uehling DT; Barnhart DD; Seastone CV
Invest Urol; 1968 Sep; 6(2):211-22. PubMed ID: 4877423
[No Abstract] [Full Text] [Related]
2. Antibody production in urinary tract infections in the rat.
Heptinstall RH; Ramsden PW
Invest Urol; 1972 Mar; 9(5):426-30. PubMed ID: 4552605
[No Abstract] [Full Text] [Related]
3. Immunoglobulin content and antibody activity in urine in experimental urinary tract infection.
Smith JW; Hand WL
J Immunol; 1972 Apr; 108(4):861-6. PubMed ID: 4623398
[No Abstract] [Full Text] [Related]
4. The antibacterial effect of normal and infected urinary bladder.
Hand WL; Smith JW; Sanford JP
J Lab Clin Med; 1971 Apr; 77(4):605-15. PubMed ID: 4928903
[No Abstract] [Full Text] [Related]
5. Antibody response of dogs to experimental infection of bladder pouch.
Darwish ME; Staubitz WJ; Scheuller EF; Rubin MI; Neter E
Invest Urol; 1968 Jul; 6(1):66-72. PubMed ID: 4874296
[No Abstract] [Full Text] [Related]
6. [Disturbance of the local vesicular defense as a cause of cystitis manifestation].
Krüger C; Grande R; Wöhrmann W; Commichau R
Zentralbl Bakteriol Orig A; 1974; 227(1-4):321-6. PubMed ID: 4154604
[No Abstract] [Full Text] [Related]
7. Antibody coating of bacteria in experimental infection of the urinary bladder.
Riedasch G; Schneider E; Ritz E; Bersch W; Möhring K
Invest Urol; 1981 Jan; 18(4):247-50. PubMed ID: 7005181
[TBL] [Abstract][Full Text] [Related]
8. The inflammatory reaction and urinary leucocytes in ascending urinary-tract infections. An experimental study on rabbits infected with Proteus vulgaris X 19 and Escherichia coli 06.
Gnarpe H; Olding L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1970; 78(2):208-14. PubMed ID: 4922733
[No Abstract] [Full Text] [Related]
9. [Serum antibodies in experimental E. coli infection of the kidneys and of the lower urinary tract].
Prát V; Konícková L; Ritzerfeld W
Cas Lek Cesk; 1969 Sep; 108(39):1153-6. PubMed ID: 4897607
[No Abstract] [Full Text] [Related]
10. Serum antibody effect on induced bladder infection.
Uehling DT; Constant M
Invest Urol; 1970 Jul; 8(1):62-5. PubMed ID: 4914799
[No Abstract] [Full Text] [Related]
11. The host-parasite relationship in urinary tract infections.
Hanson LA; Ahlstedt S; Jodal U; Kaijser B; Larsson P; Lidin-Janson G; Lincoln K; Lindberg U; Mattsby I; Olling S; Peterson H; Sohl A
Kidney Int Suppl; 1975 Aug; 4():S28-34. PubMed ID: 1104979
[No Abstract] [Full Text] [Related]
12. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
Mulvey MA; Schilling JD; Hultgren SJ
Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three techniques for the diagnosis of urinary tract infections in dogs with urolithiasis.
Gatoria IS; Saini NS; Rai TS; Dwivedi PN
J Small Anim Pract; 2006 Dec; 47(12):727-32. PubMed ID: 17201824
[TBL] [Abstract][Full Text] [Related]
14. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli.
Malaviya R; Ikeda T; Abraham SN; Malaviya R
Immunol Lett; 2004 Feb; 91(2-3):103-11. PubMed ID: 15019277
[TBL] [Abstract][Full Text] [Related]
15. Immunofluorescence studies of the bladder defense mechanism. I. Localization of Escherichia coli in the human bladder.
Drach GW; Cox CE
J Am Geriatr Soc; 1967 Dec; 15(12):1114-24. PubMed ID: 4862355
[No Abstract] [Full Text] [Related]
16. Induction of protective immunity after escherichia coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor.
Söderhäll M; Normark S; Ishikawa K; Karlsson K; Teneberg S; Winberg J; Möllby R
J Clin Invest; 1997 Jul; 100(2):364-72. PubMed ID: 9218513
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil recruitment and resistance to urinary tract infection.
Haraoka M; Hang L; Frendéus B; Godaly G; Burdick M; Strieter R; Svanborg C
J Infect Dis; 1999 Oct; 180(4):1220-9. PubMed ID: 10479151
[TBL] [Abstract][Full Text] [Related]
18. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the bladder defense mechanism by immunization.
Uehling DT; Wolf L
Invest Urol; 1969 Mar; 6(5):520-6. PubMed ID: 4887493
[No Abstract] [Full Text] [Related]
20. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
